Ticker
AQSTCompany Name
AQUESTIVE THERAPEUTICS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Cost of Revenue | Cost of Revenue Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 17.17M | 38.91% | $ 44.13M |
3/31/2025 | $ 17.14M | 31.6% | $ 54.23M |
12/31/2024 | $ 17.87M | 31.05% | $ 57.56M |
9/30/2024 | $ 18.03M | 30.61% | $ 58.9M |
6/30/2024 | $ 18.39M | 31.51% | $ 58.36M |
3/31/2024 | $ 20.48M | 39.77% | $ 51.5M |
12/31/2023 | $ 20.83M | 41.18% | $ 50.58M |
9/30/2023 | $ 21.46M | 44.65% | $ 48.06M |
6/30/2023 | $ 21.28M | 45.75% | $ 46.52M |
3/31/2023 | $ 19.91M | 42.77% | $ 46.54M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
COGS / Revenues
(=) COGS %
COGS % for AQUESTIVE THERAPEUTICS INC is calculated as follows: COGS [ $ 16.97M ] / Revenues [ $ 55.12M ]
(=) COGS % [ 30.78% ]
Minimum
Mar 31, 2021
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 3.81K |
---|---|
min | -50.26% |
max | 172.25% |
average | 46.91% |
median | 50.54% |
std | 31.59% |